Naproxen
- Product NDC
- 71297-200
- 11-digit product format
- 712970200
- Labeler code
- 71297
- Product ID
- 71297-200_b61f4f8a-87e2-3fa6-e053-2995a90a0b2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Allegis Holdings, LLC
- Application
- NDA018965
- Marketing category
- NDA
- Marketing start
- 2019-11-05
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71297-200-16 | 71297020016 | 473 mL in 1 BOTTLE (71297-200-16) | 473 ml | 2019-11-05 | 0000-00-00 | No | No | Current |